Levodopa-responsive aromatic L-amino acid decarboxylase deficiency
- PMID: 14991824
- DOI: 10.1002/ana.20055
Levodopa-responsive aromatic L-amino acid decarboxylase deficiency
Abstract
We report three siblings, who were treated empirically with levodopa combined with carbidopa. There was an immediate therapeutic response. Biochemical investigation surprisingly showed the clinical phenotype to be caused by aromatic L-amino acid decarboxylase deficiency. Molecular characterization showed a homozygous point mutation (c.387 G-->A) in exon 3. Kinetic studies showed the mutation to decrease the binding affinity for the substrate. This, combined with structural modeling suggesting alteration of active site configuration, provided an explanation for the therapeutic response to levodopa.
Similar articles
-
Evolution of the bioavailability and other pharmacokinetic parameters of levodopa (with carbidopa) in rabbits.Methods Find Exp Clin Pharmacol. 2008 Jul-Aug;30(6):451-7. doi: 10.1358/mf.2008.30.6.1186079. Methods Find Exp Clin Pharmacol. 2008. PMID: 18850046
-
Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency From Drug-Induced Metabolite Elevations.Pediatr Neurol. 2017 Oct;75:66-72. doi: 10.1016/j.pediatrneurol.2017.06.014. Epub 2017 Jun 29. Pediatr Neurol. 2017. PMID: 28823629
-
L-dopa-resistant Parkinsonism due to dopa decarboxylase deficiency?Ann Neurol. 1981 Jul;10(1):64-5. doi: 10.1002/ana.410100117. Ann Neurol. 1981. PMID: 7271235 No abstract available.
-
Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.Med Lett Drugs Ther. 2005 Jan 31;47(1201):12. Med Lett Drugs Ther. 2005. PMID: 15706700
-
Aromatic L-amino acid decarboxylase: conformational change in the flexible region around Arg334 is required during the transaldimination process.Protein Sci. 1998 Aug;7(8):1802-10. doi: 10.1002/pro.5560070816. Protein Sci. 1998. PMID: 10082378 Free PMC article.
Cited by
-
Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review.Behav Neurol. 2022 Oct 11;2022:2210555. doi: 10.1155/2022/2210555. eCollection 2022. Behav Neurol. 2022. PMID: 36268467 Free PMC article. Review.
-
Kinetic analyses guide the therapeutic decision in a novel form of moderate aromatic Acid decarboxylase deficiency.JIMD Rep. 2012;3:25-32. doi: 10.1007/8904_2011_43. Epub 2011 Sep 16. JIMD Rep. 2012. PMID: 23430870 Free PMC article.
-
Clinical Profile and Outcome of Indian Children with Aromatic L-Amino Acid Decarboxylase Deficiency: A primary CSF Neurotransmitter Disorder Mimicking as Dyskinetic Cerebral Palsy.J Pediatr Genet. 2021 Jun;10(2):85-91. doi: 10.1055/s-0040-1714690. Epub 2020 Jul 27. J Pediatr Genet. 2021. PMID: 33996177 Free PMC article.
-
Report of two never treated adult sisters with aromatic L-amino Acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?JIMD Rep. 2015;15:39-45. doi: 10.1007/8904_2014_295. Epub 2014 May 1. JIMD Rep. 2015. PMID: 24788355 Free PMC article.
-
Aromatic Amino Acid Decarboxylase Deficiency: The Added Value of Biochemistry.Int J Mol Sci. 2021 Mar 19;22(6):3146. doi: 10.3390/ijms22063146. Int J Mol Sci. 2021. PMID: 33808712 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases